sb 203580 has been researched along with eclalbasaponin i in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (eclalbasaponin i) | Trials (eclalbasaponin i) | Recent Studies (post-2010) (eclalbasaponin i) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 9 | 0 | 8 |
| Protein | Taxonomy | sb 203580 (IC50) | eclalbasaponin i (IC50) |
|---|---|---|---|
| Tissue factor | Homo sapiens (human) | 0.0096 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, T; Shang, XY; Song, SJ; Song, XY; Wang, W; Yao, GD; Zhang, Y; Zhang, YY | 1 |
1 other study(ies) available for sb 203580 and eclalbasaponin i
| Article | Year |
|---|---|
Eclalbasaponin I causes mitophagy to repress oxidative stress-induced apoptosis via activation of p38 and ERK in SH-SY5Y cells.
Topics: Apoptosis; Aralia; Cell Survival; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Humans; Hydrogen Peroxide; Imidazoles; Mitophagy; Models, Molecular; Molecular Conformation; Neuroprotective Agents; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyrazoles; Pyridazines; Pyridines; Saponins; Tumor Cells, Cultured | 2019 |